Website
News25/Ratings7
Latest news
25 items- SECDanimer Scientific Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Danimer Scientific Inc.SCHEDULE 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- INSIDERChief Financial Officer Hajost Michael A converted options into 859 shares and covered exercise/tax liability with 301 shares, increasing direct ownership by 31% to 2,334 units (SEC Form 4)4 - Danimer Scientific, Inc. (0001779020) (Issuer)
- INSIDERDirector Moody David Jesse converted options into 646 shares (SEC Form 4)4 - Danimer Scientific, Inc. (0001779020) (Issuer)
- SECSEC Form 25-NSE filed by Danimer Scientific Inc.25-NSE - Danimer Scientific, Inc. (0001779020) (Subject)
- INSIDERSEC Form 4 filed by Director Croskrey Stephen4 - Danimer Scientific, Inc. (0001779020) (Issuer)
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- PRDanimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace–Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- PRDanimer Scientific Takes Action to Strengthen Capital StructureAnnounces Issuance of $11,250,000 Super Senior Secured Promissory Note Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that the Company issued a super senior secured promissory note (the "Secured Loan") in an aggregate principal amount of $11,250,000 to certain lenders under its existing term loan financing agreement, as well as certain additional lenders. The Secured Loan provides for $11,250,000 gross proceeds, less fees and expenses. The Secured Loan has a two-year maturity and accrues interest at 15.0% per annum, which interest is payab
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECDanimer Scientific Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Danimer Scientific, Inc. (0001779020) (Filer)
- ANALYSTTD Cowen reiterated coverage on Danimer Scientific with a new price targetTD Cowen reiterated coverage of Danimer Scientific with a rating of Hold and set a new price target of $5.50 from $40.00 previously
- PRTerraNova Capital Equities announces three transactions totaling $45 MillionNEW YORK, Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted as the sole advisor to Danimer Scientific, Inc. (NYSE:DNMR) on a $20 Million revolving credit facility. TerraNova is pleased to announce its role as the exclusive advisor to Danimer Scientific in securing a strategic ABL agreement with Mountain Ridge Capital. This $20 million facility, collateralized by the Com
- ANALYSTDanimer Scientific downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Danimer Scientific from Neutral to Underweight and set a new price target of $4.00 from $40.00 previously
- SECSEC Form 424B3 filed by Danimer Scientific Inc.424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
- SECSEC Form 10-Q filed by Danimer Scientific Inc.10-Q - Danimer Scientific, Inc. (0001779020) (Filer)